Halix has inked an agreement with AstraZeneca (LON:AZN) for large-scale drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine. The privately owned Dutch contract development and manufacturing organization will carry out the manufacturing services from its cGMP facility at the Leiden Bio Science Park.  The company has expanded the facility with two additional viral…